Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 9Glioma 7Brain Neoplasms 6Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Neoplasm Metastasis 4Sarcoma 3Melanoma 3Lung Neoplasms 3Glioblastoma 3Colonic Neoplasms 3Carcinoma, Hepatocellular 3Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroendocrine Tumors 2Neuroblastoma 2Lymphoma, Large B-Cell, Diffuse 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2von Hippel-Lindau Disease 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Rhabdomyosarcoma 1

Interventions

poly ICLC 1Magnetic Resonance Spectroscopy 1Flow Cytometry 1Enzyme-Linked Immunosorbent Assay 189Zr-bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Inflammatory Breast Neoplasms × Magnetic Resonance Spectroscopy × Clear all
NCT01894451 2019-12-12

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Completed
2 enrolled
Breast

Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡